We’re pleased to announce that we have now opened our third treatment arm, testing Ursodeoxycholic acid (UDCA) as a potential disease-modifying treatment for Parkinson’s! This marks a major milestone for the trial and another important step forward in our mission to find treatments that could slow or stop Parkinson’s progression! If you’d like to learn more about UDCA, visit ou ...
News & Publications
Join the EJS ACT-PD Trial
If you are interested in participating in the EJS ACT-PD trial, you will need to first complete the Registration of Interest.
Visit our Registration of Interest Page for more information and to find the link to the Registration Form.